Does CANGRELOR TETRASODIUM Cause Off label use? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Off label use have been filed in association with CANGRELOR TETRASODIUM. This represents 64.7% of all adverse event reports for CANGRELOR TETRASODIUM.
11
Reports of Off label use with CANGRELOR TETRASODIUM
64.7%
of all CANGRELOR TETRASODIUM reports
0
Deaths
7
Hospitalizations
How Dangerous Is Off label use From CANGRELOR TETRASODIUM?
Of the 11 reports, 7 (63.6%) required hospitalization, and 6 (54.5%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANGRELOR TETRASODIUM. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does CANGRELOR TETRASODIUM Cause?
Drug interaction (7)
Thrombocytopenia (7)
Vascular stent thrombosis (7)
Acute myocardial infarction (6)
Colitis ischaemic (6)
Drug level decreased (6)
Electrocardiogram st segment elevation (6)
Eosinophil cationic protein increased (6)
Eosinophilia (6)
Erythema (6)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)